Anti-HBV and cytotoxic activities of pyranocoumarin derivatives

Bioorganic and Medicinal Chemistry

Volumn 17, Issue 16, 2009, Pages 6137-6143

  Su, Chung Ren ^a   Yeh, Sheau Farn ^b   Liu, Chih Miem ^b   Damu, Amooru G ^a   Kuo, Tsung Hsiao ^a   Chiang, Po Cheng ^c   Bastow, Kenneth F ^c   Lee, Kuo Hsiung ^c   Wu, Tian Shung ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c University of North Carolina   (United States)

Author keywords

Anti HBV; Cytotoxic; Pyranocoumarin derivatives

Indexed keywords

10 (1,1 DIMETHYLPROPYL) 5 HYDROXY 8,8 DIMETHYL 7,8 DIHYDRO 6H PYRANO[3,2 GAMMA]CHROMEN 2 ONE; 10 (1,1 DIMETHYLPROPYL) 5 HYDROXY 8,8 DIMETHYL 7,8 DIHYDROPYRANO[3,2 GAMMA]CHROMEN 2,6 DIONE; 5 HYDROXY 8,8 DIMETHYL 10 (1 METHYL 1 OXIRANYLETHYL) 7,8 DIHYDROPYRANO[3,2 GAMMA]CHROMEN 2,6 DIONE; ANTIVIRUS AGENT; CLAUSARIN; CLAUSENA EXCAVATA EXTRACT; CLAUSENIDIN; HEPATITIS B SURFACE ANTIGEN; NORDENTATIN; PYRANOCOUMARIN DERIVATIVE; UNCLASSIFIED DRUG; XANTHOXYLETIN;

ANTIVIRAL ACTIVITY; ARTICLE; CANCER CELL CULTURE; CLAUSENA EXCAVATA; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG POTENCY; DRUG SYNTHESIS; HEPATITIS B VIRUS; MEDICINAL PLANT; MULTIDRUG RESISTANCE; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CELL LINE, TUMOR; CLAUSENA; DRUG SCREENING ASSAYS, ANTITUMOR; HEPATITIS B VIRUS; HUMANS; PLANTS, MEDICINAL; PYRANOCOUMARINS; STRUCTURE-ACTIVITY RELATIONSHIP;

CLAUSENA EXCAVATA; HEPATITIS B VIRUS;

EID: 68149119176     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.12.007     Document Type: Article

References (21)

1. Huang S.C., Wu P.L., and Wu T.S. Phytochemistry 44 (1997) 179-181
2. Sasaki, S. Khoyo Taiwan Minkan Yakyo Shokubutsu Shi, Khobunkan, Taipei, 1924, p 36.
3. Boonsong K., Ngampong K., Arunrat S., Chanita N., and Chalobon Y. Phytother. Res. 19 (2005) 728-731
4. Arunrat S., Ngampong K., Boonsong K., Sida P., John W.D., Thomas F.S., Yuth N., and Sasarose R. Planta Med. 69 (2003) 155-157
5. Malik A.H., and Lee W.M. Ann. Int. Med. 132 (2000) 723-731
6. Chang M.H., Chen C.J., Lai M.S., Hsu H.M., Wu T.C., Kong M.S., and Liang D.C. New Eng. J. Med. 336 (1997) 1855-1859
7. Beasley R.P. Cancer 61 (1998) 1942-1956
8. Liaw Y.F. J. Viral Hepatitis 9 (2002) 393-399
9. Lo K.J., Lee S.D., Tsai Y.T., Chan C.Y., Chen G.H., and Yeh C.L. Hepatology 6 (1988) 1647-1650
10. Franco J., and Saeian K. J. Vasc. Interv. Radiol. 13 (2002) S191-196
11. Mohanty S.R., Kupfer S.S., and Khiani V. Nat. Clin. Pract. Gastroenterol. Hepatol. 3 (2006) 446-458
12. Fu L., and Cheng Y.C. Antimicrob. Agents Chemother. 44 (2000) 3402-3407
13. Fu L., and Cheng Y.C. Biochem. Pharmacol. 55 (1998) 1567-1572
14. Leung N.W.Y., Lai C.L., Chang T.T., Guan R., Lee C.M., Ng K.Y., Lim S.G., Wu P.C., Dent J.C., Edmundson S., Condreay L.D., and Chien R.N. Hepatology 33 (2001) 1527-1532
15. Tomimatsu T., Hashimoto M., Shingu T., and Tori K. Tetrahedron 28 (1972) 2003-2010
16. Murray R.D.H., and Jorge Z.D. Tetrahedron 40 (1984) 3133-3136
17. Nicolaou K.C., Pfefferkorn J.A., Barluenga S., Mitchell H.J., Roecker A.J., and Cao G.Q. J. Am. Soc. Chem. 122 (2000) 9968-9976
18. Parker S.E., Gray A.I., and Waterman P.G. Heterocycles 27 (1988) 1561-1564
19. Bujon J., Camps F., and Messeguer A. Tetrahedron Lett. 31 (1990) 5235-5236
20. Levitz S.M., and Diamond R.D. J. Infect. Dis. 152 (1985) 938-945
21. Wang X., Bastow K.F., Sun C.M., Lin Y.L., Yu H.J., Don M.J., Wu T.S., Nakamura S., and Lee K.H. J. Med. Chem. 47 (2004) 5816-5819